Highlights
NASDAQ: ATXI       Avenue Therapeutics Inc
Last Price Today's Change   Day's Range   Trading Volume
5.71   -0.07 (1.21%)  5.67 - 5.81  1,669

Overview

 
Avg Volume (4 weeks):21,585
4 Weeks Range:4.963 - 6.15
4 Weeks Price Volatility (%):
62.93%
52 Weeks Range:4.13 - 7.98
52 Weeks Price Volatility (%):
41.04%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Avenue Therapeutics Inc is a specialty pharmaceutical company. It is focused on the development and commercialization of an intravenous, or IV, formulation of tramadol HCl, or IV Tramadol, for the management of moderate to moderately severe postoperative pain. The company's primary objective is to establish IV Tramadol as an invaluable part of a treating physician's repertoire of available pharmaceutical options for the management of postoperative pain.

  Be the first to like this.
 


 

2954  2614  494  2908 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CHK 0.702+0.032 
 FCEL 0.827+0.282 
 AMD 37.52+0.81 
 ET 11.16-0.50 
 GE 11.29-0.13 
 AABA 19.630.00 
 DIS 148.72+10.14 
 BAC 32.79-0.30 
 F 8.81-0.23 
 UBER 26.71+0.01 
Partners & Brokers